Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Phase Separation and Molecular Intermixing in Polymer-Fullerene Bulk Heterojunction Thin Films
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer
Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402
Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemonaive, Advanced, Non-small Cell Lung Cancer Patients Aged 70 Years or Older
Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment
Phase transitions of Dirac electrons in bismuth
Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
Phase of molecular ink in nanoscale direct deposition processes
Phase I Study Combining Treatment with Temsirolimus and Sunitinib Malate in Patients with Advanced Renal Cell Carcinoma
Phase II Trial of Carboplatin and Paclitaxel in Papillary Renal Cell Carcinoma
Phase variation of F165(1) (Prs-like) fimbriae from Escherichia coli causing septicaemia in animals
Phase 1/2 clinical trial of interferon alpha 2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma
Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer
Phase I Study of Combination Chemotherapy Consisting of Paclitaxel, Cisplatin, and S-1 in Patients with Unresectable Gastric Cancer (KOGC-02)
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer
Phase transformation and two-mode phonon behavior of (1-x) [Ba Zr0.025Ti0.975O3]-(x) [BiFeO3] solid solutions
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer
Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients
Phase Separation and Magnetoelectric Properties of Locally Induced States in Manganites
Phase synchronization of coupled bursting neurons and the generalized Kuramoto model
Phase synchronization between collective rhythms of fully locked oscillator groups
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer
Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence
Phase-change related epigenetic and physiological changes in Pinus radiata D. Don
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer
Phase I Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients with Locally Advanced Soft Tissue Sarcoma of the Extremity
Phase of firing as a local window for efficient neuronal computation: tonic and phasic mechanisms in the control of theta spike phase
Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer
Phase I Study of Everolimus, Cetuximab and Irinotecan as Second-line Therapy in Metastatic Colorectal Cancer
Phase II Trial of S-1 as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1,-2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors
Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors
Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
Phase I Trial of Sorafenib in Combination With 5-Fluorouracil/Leucovorin in Advanced Solid Tumors
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours
Phase I Trial of Everolimus Plus Sorafenib for Patients with Advanced Renal Cell Cancer
Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas
Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma
Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors
Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
Phase diagram of nondegenerate twisted mass fermions
Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
Phases of flavor neutrino masses and CP-violation
Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
Phase transitions and rare-earth magnetism in hexagonal and orthorhombic DyMnO3 single crystals
Phase transformations in copper oxide nanowires
Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer
Phase-space mixing and the merging of cusps
Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancer
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
Phase I Trial of Wilms%26apos; Tumor 1 (WT1) Peptide Vaccine with GM-CSF or CpG in Patients with Solid Malignancy
Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer
Phase-rectified signal averaging detects quasi-periodicities in non-stationary data
Phase II Cancer Prevention Clinical Trials
Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2-Dependent and Other Solid Tumors